Sponsored By:

Top 10 Dow Dividend Stocks for December

Want some reliable income? Try one of these blue-chip companies

      View All  

#7: Pfizer

pfe Top 10 Dow Dividend Stocks for DecemberCurrent Dividend Yield: 3.47%
Performance So Far in 2012: +17%

The Big Pharma crowd has long been a mainstay among the top-paying Dow dividend stocks, and more broadly, is close friends with dividend investors. Pfizer is no exception.

Not only does Pfizer yield an attractive 3.47%, but its shares have outperformed the market despite a number of setbacks. Back in August, PFE and Johnson & Johnson shut the door on studies of IV-delivered bapineuzumab as an Alzheimer’s treatment. A little more than a month ago, Pfizer reported profits that fell 14% thanks mostly to a slide in sales of Lipitor — its cholesterol drug that just went off-patent. And most recently (and most embarrassingly), Pfizer had to report the theft of $750,000 worth of gold dust at a Chesterfield, Mo., lab.

The poor earnings report knocked out gains made thanks to things like an animal health spinoff and its big leukemia drug approval in September, but shares have rebounded more than 8% from a mid-November low, thanks in part to excitement over progress in drugs treating breast cancer and preventing blood clots. Plus, there’s reason to really start believing in Pfizer’s pipeline.


Article printed from InvestorPlace Media, http://investorplace.com/2012/12/top-10-dow-dividend-stocks-for-december/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.